NASDAQ · Healthcare · Biotechnology
Anixa Biosciences, Inc.
ANIX
Anixa Biosciences, Inc. CEO Amit Kumar · Market cap $94.9M.
$2.79
+0.17 · +6.49%
52w hi $5.4652w lo $2.32
Off 52w high 52.2%
58
ROUTINE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $5.83
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 12 | Amit Kumar | Chief Executive Officer | Buy | 21,000 | $2.50 | +$53K | 58 |
| Jan 28 | Arnold M Baskies | Buy | 10,000 | $3.04 | +$30K | 34 | |
| Jul 31 | Lewis H Titterton jr | Buy | 10,000 | $3.08 | +$31K | 31 | |
| Jul 11 | Lewis H Titterton jr | Buy | 10,000 | $3.14 | +$31K | 31 | |
| Jun 04 | Amit Kumar | Chief Executive Officer | Buy | 10,000 | $2.85 | +$29K | 54 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun